Insulin glargine and lixisenatide and Zodryl DAC
Determining the interaction of Insulin glargine and lixisenatide and Zodryl DAC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: chlorpheniramine / codeine / pseudoephedrine
Brand name: Zodryl DAC, Phenylhistine DH Expectorant, Tricode AR, Novahistine DH, Phenylhistine DH, Dihistine DH, Decohistine DH, Codehist DH, Novadyne DH, Co-Histine DH, Ryna-C, Codahistine-DH Elixir
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Zodryl Dec 60
- Insulin glargine and lixisenatide-Zofran
- Insulin glargine and lixisenatide-Zofran (Ondansetron Injection)
- Insulin glargine and lixisenatide-Zofran (Ondansetron Oral Solution)
- Insulin glargine and lixisenatide-Zofran (Ondansetron Tablets)
- Insulin glargine and lixisenatide-Zofran injection
- Zodryl DAC-Insulin glargine and lixisenatide Subcutaneous
- Zodryl DAC-Insulin glargine, recombinant Subcutaneous
- Zodryl DAC-Insulin glulisine
- Zodryl DAC-Insulin Glulisine (Cartridges and Pens)
- Zodryl DAC-Insulin Glulisine (Vials)
- Zodryl DAC-Insulin glulisine Subcutaneous